| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Vaishnaw Akshay | President of R&D, Director | 301 BINNEY STREET, CAMBRIDGE | /s/ Junlin Ho, Attorney-in-Fact for Akshay Vaishnaw | 06 May 2025 | 0001458494 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | SRRK | Stock Option (Right to Buy) | Award | $0 | +110K | $0.00 | 110K | 02 May 2025 | Common Stock | 110K | $32.91 | Direct | F1 |
| Id | Content |
|---|---|
| F1 | 25% of the shares underlying this option shall vest on April 27, 2026, with the remainder vesting in twelve equal quarterly installments thereafter; provided the reporting person continues to have a service relationship with the Issuer on each such vesting date. |